acquired
Stage
About
Biovitrum was a Swedish biopharmaceutical company that was listed on OMX Stockholm in 2006 and in 2010 merged with Swedish Orphan to form Swedish Orphan Biovitrum (Sobi).
Explore Biovitrum's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.